Bursa Alert
Global Market
NewsCIMB Research maintains Add on Tune Insurance, trims target price to RM3
Page 1 of 1
CIMB Research maintains Add on Tune Insurance, trims target price to RM3
by Cals Wed 19 Nov 2014, 02:22
CIMB Research maintains Add on Tune Insurance, trims target price to RM3
KUALA LUMPUR (Nov 18): CIMB Research has maintained its Add rating on Tune Ins Holdings Bhd ([You must be registered and logged in to see this image.] Financial Dashboard) at RM2.07 with a lower target price of RM3 (from RM3.05) and said Tune’s 9MFY14 net profit was below expectations at 64% of house full-year forecast and 65% of consensus.
In a note Nov 17, the research house said this was because it had under-projected the claims ratio.
“Hence, we raise the ratio from 30% to 34% for FY14.
“This leads to a drop in our FY14 EPS forecasts and DDM-based target price (COE of 9.2%; LT growth of 5%). However, our FY15-16 numbers are unchanged,” it said.
CIMB Research said despite the weaker-than-expected 9M results, it was unwavering on its Add recommendation on Tune, as the potential re-rating catalysts were intact, including 1) the swift expansion of its travel insurance business in the region, with the new market in the Middle East, 2) the growth prospects in the non-life insurance market in Thailand and 3) more tie-ups with other airlines.
At 9.13am, Tune fell 0.97% or two sen to RM2.05 with 3,000 shares done.
KUALA LUMPUR (Nov 18): CIMB Research has maintained its Add rating on Tune Ins Holdings Bhd ([You must be registered and logged in to see this image.] Financial Dashboard) at RM2.07 with a lower target price of RM3 (from RM3.05) and said Tune’s 9MFY14 net profit was below expectations at 64% of house full-year forecast and 65% of consensus.
In a note Nov 17, the research house said this was because it had under-projected the claims ratio.
“Hence, we raise the ratio from 30% to 34% for FY14.
“This leads to a drop in our FY14 EPS forecasts and DDM-based target price (COE of 9.2%; LT growth of 5%). However, our FY15-16 numbers are unchanged,” it said.
CIMB Research said despite the weaker-than-expected 9M results, it was unwavering on its Add recommendation on Tune, as the potential re-rating catalysts were intact, including 1) the swift expansion of its travel insurance business in the region, with the new market in the Middle East, 2) the growth prospects in the non-life insurance market in Thailand and 3) more tie-ups with other airlines.
At 9.13am, Tune fell 0.97% or two sen to RM2.05 with 3,000 shares done.
Cals- Administrator
- Posts : 25277 Credits : 57721 Reputation : 1766
Join date : 2011-09-08
Location : global
Comments : “My plan of trading was sound enough and won oftener that it lost. If I had stuck to it Iâ€
d have been right perhaps as often as seven out of ten times.â€
Stock Exposure : Technical Analysis / Fundamental Analysis / Mental Analysis
Similar topics» Affin IB Research maintains Reduce on CIMB, trims target price
» Alliance IB Research maintains Neutral on CIMB, trims target price
» CIMB Research maintains Outperform on Tune Insurance, ups target price to RM2.54
» CIMB Research maintains Hold on TM, trims target to RM6.40
» HLIB Research maintains Buy on Adventa, trims target price to RM1.20
» Alliance IB Research maintains Neutral on CIMB, trims target price
» CIMB Research maintains Outperform on Tune Insurance, ups target price to RM2.54
» CIMB Research maintains Hold on TM, trims target to RM6.40
» HLIB Research maintains Buy on Adventa, trims target price to RM1.20
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum